KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Total Debt (2016 - 2025)

Opko Health (OPK) has disclosed Total Debt for 16 consecutive years, with $12.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt fell 95.2% year-over-year to $12.5 million, compared with a TTM value of $12.5 million through Dec 2025, down 95.2%, and an annual FY2025 reading of $12.5 million, down 95.2% over the prior year.
  • Total Debt was $12.5 million for Q4 2025 at Opko Health, down from $15.3 million in the prior quarter.
  • Across five years, Total Debt topped out at $260.4 million in Q4 2024 and bottomed at $9.2 million in Q4 2022.
  • Average Total Debt over 5 years is $45.1 million, with a median of $18.5 million recorded in 2021.
  • Peak annual rise in Total Debt hit 860.45% in 2025, while the deepest fall reached 95.2% in 2025.
  • Year by year, Total Debt stood at $14.7 million in 2021, then plummeted by 37.67% to $9.2 million in 2022, then skyrocketed by 282.12% to $35.0 million in 2023, then skyrocketed by 644.03% to $260.4 million in 2024, then tumbled by 95.2% to $12.5 million in 2025.
  • Business Quant data shows Total Debt for OPK at $12.5 million in Q4 2025, $15.3 million in Q3 2025, and $16.8 million in Q2 2025.